AptarGroup shareholders approved all ballot items as the packaging firm reported $3.8 billion in 2025 sales and outlined CEO succession.
AptarGroup announced CEO Stephan Tanda will retire on September 1, 2026, with Gael Touya, current head of Aptar Pharma, succeeding him. Tanda will remain as an adviser through year-end to ensure a smooth transition.
The company reported 5% sales growth to $3.8 billion in 2025, driven by its Pharma segment. Aptar returned $486 million to shareholders via buybacks and dividends. First-quarter 2026 sales rose 11% reported, while long-term targets remain unchanged.
Shareholders at the annual meeting approved all ballot items, including director elections, executive compensation, and auditor ratification. No additional shareholder motions were presented.